tiprankstipranks
Trending News
More News >
Inhibikase Therapeutics, Inc. (IKT)
:IKT
Advertisement

Inhibikase Therapeutics (IKT) Similar Stocks

Compare
166 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Inhibikase Therapeutics
$1.79
$137.11M
29.71%
1 Buy
0 Hold
0 Sell
Moderate Buy
Rezolute
$7.20
$626.37M
54.18%
5 Buy
0 Hold
0 Sell
Strong Buy
AC Immune SA
$2.07
$207.78M
-32.35%
2 Buy
1 Hold
0 Sell
Moderate Buy
Diamedica Therapeutics
$5.98
$312.46M
51.39%
3 Buy
0 Hold
0 Sell
Strong Buy
Tango Therapeutics
$6.90
$743.22M
-39.47%
5 Buy
0 Hold
0 Sell
Strong Buy
Nanobiotix
$8.99
$410.80M
75.24%
1 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
IKT
Inhibikase Therapeutics
1.79
0.40
28.78%
RZLT
Rezolute
7.20
2.45
51.58%
ACIU
AC Immune SA
2.07
-1.16
-35.91%
DMAC
Diamedica Therapeutics
5.98
2.04
51.78%
TNGX
Tango Therapeutics
6.90
-4.22
-37.95%
NBTX
Nanobiotix
8.99
3.37
59.96%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis